Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Down 99.6% in March

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,800 shares, a drop of 99.6% from the February 28th total of 499,900 shares. Based on an average daily volume of 7,236,000 shares, the short-interest ratio is presently 0.0 days.

Enzolytics Trading Up 16.7 %

Enzolytics stock opened at $0.00 on Thursday. Enzolytics has a one year low of $0.00 and a one year high of $0.01.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.